(S)-tert-butyl 1-(cyclopentylamino)-8-(hydroxyamino)-1,8-dioxooctan-2-ylcarbamate | 1260097-47-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (S)-tert-butyl 1-(cyclopentylamino)-8-(hydroxyamino)-1,8-dioxooctan-2-ylcarbamate
• 英文别名: tert-butyl N-[(2S)-1-(cyclopentylamino)-8-(hydroxyamino)-1,8-dioxooctan-2-yl]carbamate
• CAS: 1260097-47-9
• 化学式: C₁₈H₃₃N₃O₅
• 分子量: 371.477
• InChiKey: YKINZQJOQFMNPU-AWEZNQCLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  26
• 可旋转键数：
  11
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  117
• 氢给体数：
  4
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  methyl (7S)-8-(cyclopentylamino)-7-[(2-methylpropan-2-yl)oxycarbonylamino]-8-oxooctanoate 在 sodium methylate 、 盐酸羟胺 作用下， 以 甲醇 为溶剂， 反应 0.67h， 以41%的产率得到(S)-tert-butyl 1-(cyclopentylamino)-8-(hydroxyamino)-1,8-dioxooctan-2-ylcarbamate
  参考文献：
  名称：

  Inhibitors selective for HDAC6 in enzymes and cells

  摘要：

  Histone deacetylase inhibitors with anticancer or anti-inflammatory activity bind to Class I or Class I and II HDAC enzymes. Here we compare selectivity of inhibitors of a Class II HDAC enzyme (HDAC6) and find one that retains high selectivity in macrophages. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.09.100

文献信息

• [EN] COMPOUNDS AND METHODS FOR ANTICOAGULATION THERAPY<br/>[FR] COMPOSÉS ET PROCÉDÉS POUR TRAITEMENT ANTICOAGULANT
  申请人：FUNDACIÓN PARA LA INVESTIGACIÓN MÉDICA APLIC

  公开号：WO2016120432A1

  公开（公告）日：2016-08-04

  The invention relates to certain compounds that are inducers of Heat shock 70 kDa protein 1A/1B (HSPA1A/B) and their use for anticoagulation therapy; and to a method for anticoagulation therapy that comprises the administration of one of these inducer compounds. It has been here proved that induction of Heat shock 70 kDa protein 1A/1B by administration of one of these inducer compounds has antithrombotic effects without accelerating or altering bleeding time.
• Inhibitors selective for HDAC6 in enzymes and cells
  作者：Praveer K. Gupta、Robert C. Reid、Ligong Liu、Andrew J. Lucke、Steve A. Broomfield、Melanie R. Andrews、Matthew J. Sweet、David P. Fairlie

  DOI：10.1016/j.bmcl.2010.09.100

  日期：2010.12

  Histone deacetylase inhibitors with anticancer or anti-inflammatory activity bind to Class I or Class I and II HDAC enzymes. Here we compare selectivity of inhibitors of a Class II HDAC enzyme (HDAC6) and find one that retains high selectivity in macrophages. (C) 2010 Elsevier Ltd. All rights reserved.